Yuyu Pharma, Inc. (KRX:000220)
3,885.00
+45.00 (1.17%)
Last updated: Sep 1, 2026, 1:19 PM KST
Yuyu Pharma Revenue
Yuyu Pharma had revenue of 36.70B KRW in the quarter ending June 30, 2026, with 2.37% growth. This brings the company's revenue in the last twelve months to 144.37B, up 6.69% year-over-year. In the year 2025, Yuyu Pharma had annual revenue of 140.88B with 5.81% growth.
Revenue (ttm)
144.37B
Revenue Growth
+6.69%
P/S Ratio
0.42
Revenue / Employee
568.39M
Employees
254
Market Cap
60.47B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 140.88B | 7.74B | 5.81% |
| Dec 31, 2024 | 133.15B | -4.06B | -2.96% |
| Dec 31, 2023 | 137.21B | -1.67B | -1.20% |
| Dec 31, 2022 | 138.88B | 23.23B | 20.08% |
| Dec 31, 2021 | 115.66B | 17.54B | 17.87% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Jeil Pharma Holdings | 630.89B |
| Ildong Holdings | 607.65B |
| HANDOK | 560.89B |
| HLB Pharmaceutical | 251.95B |
| MYUNGMOON Pharm co.,Ltd | 199.82B |
| Kukje Pharma | 181.27B |
| CKD Bio | 159.93B |
| CMG Pharmaceutical | 115.71B |